Cascades Capital Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$828K Buy
3,386
+8
+0.2% +$1.86K 0.35% 57
2025
Q4
$699K Buy
3,378
+10
+0.3% +$1.98K 0.29% 62
2025
Q3
$625K Sell
3,368
-6
-0.2% -$1.03K 0.27% 63
2025
Q2
$515K Buy
3,374
+127
+4% +$19.5K 0.27% 60
2025
Q1
$538K Buy
3,247
+11
+0.3% +$1.72K 0.29% 56
2024
Q4
$468K Sell
3,236
-306
-9% -$47.4K 0.25% 62
2024
Q3
$574K Buy
+3,542
New +$564K 0.32% 56

Other funds holding JNJ

Cascades Capital Asset Management's JNJ Position: Q1 2026 in Review

Cascades Capital Asset Management increased its Johnson & Johnson (JNJ) stake by 0.24% in Q1 2026, buying an estimated $1.86K and bringing the position to 3,386 shares worth $828K. The position accounts for 0.35% of the portfolio, ranked #57.

Cascades Capital Asset Management first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cascades Capital Asset Management held 3,386 shares of Johnson & Johnson worth $828K as of Q1 2026.
  • Cascades Capital Asset Management bought 8 Johnson & Johnson shares in Q1 2026, an estimated $1.86K.
  • Johnson & Johnson made up 0.35% of Cascades Capital Asset Management's portfolio in Q1 2026, its #57 holding.
  • Cascades Capital Asset Management first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cascades Capital Asset Management's 13F filing for Q1 2026, filed 15 May 2026.